SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?


To: Ed Schultz who wrote (13908)1/27/1998 3:36:00 PM
From: iceburg  Respond to of 29386
 
Ed,

Why do you still own this stock? Please answer the question this time.

Steve



To: Ed Schultz who wrote (13908)1/27/1998 3:49:00 PM
From: Eleder2020  Read Replies (1) | Respond to of 29386
 
>>>> Why do you think Johnson & Johnson can sell a bottle of Tylenol for $7 which costs them less than 50 cents to produce? Why do you think a stupid pet rock was so successful years ago?<<<<
Because they had the BEST PERFORMING and MOST COMPETITIVELY priced switch much like ANCR?
Are you trying to say the Silkworm is going to be a one hit wonder much like The Pet Rock or that the Silkworm should be renamed The Pet Switch or that after using the more expensive per port Silkworm you next need an overpriced tylenol.<g>



To: Ed Schultz who wrote (13908)1/28/1998 12:15:00 AM
From: Thom Handabaka  Respond to of 29386
 
Ed,

Microsoft and J&J are successful at selling to the masses. This product is not for the masses! Most of the engineers I work with evaluate product and its capabilities followed by support. They don't get hung up on color schemes or sentiment. They look at performance.

While we are at it, anyone remeber Salarino Sanchez?

Thom



To: Ed Schultz who wrote (13908)1/28/1998 6:50:00 PM
From: mike linnihan  Read Replies (1) | Respond to of 29386
 
FWIW
Kinn reported earnings today, you might want to read the presidents
explination of why they lost 14 cents per share, gives a little insight into the performance of the stocks they follow.